Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy.
Shemonti HasanOnilia ZorioB Mark KeeganBrian G WeinshenkerEoin P FlanaganW Oliver TobinOrhun H KantarciMichel ToledanoSean J PittockSebastian Lopez-ChiribogaAnastasia ZekeridouCristina Valencia SanchezPublished in: Journal of neurology (2023)